Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Eur J Med Chem ; 121: 517-529, 2016 Oct 04.
Artículo en Inglés | MEDLINE | ID: mdl-27318976

RESUMEN

5-Chloro-3-ethyl-N-(4-(piperidin-1-yl)phenethyl)-1H-indole-2-carboxamide (ORG27569, 1) is a prototypical allosteric modulator for the cannabinoid CB1 receptor. Based on this indole-2-carboxamide scaffold, we designed and synthesized novel CB1 allosteric modulators that possess photoactivatable functionalities, which include benzophenone, phenyl azide, aliphatic azide and phenyltrifluoromethyldiazrine. To assess their allosteric effects, the dissociation constant (KB) and allosteric binding cooperativity factor (α) were determined and compared to their parent compounds. Within this series, benzophenone-containing compounds 26 and 27, phenylazide-containing compound 28, and the aliphatic azide containing compound 36b showed allosteric binding parameters (KB and α) comparable to their parent compound 1, 7, 8, and 9, respectively. We further assessed these modulators for their impact on G-protein coupling activity. Interestingly, these compounds exhibited negative allosteric modulator properties in a manner similar to their parent compounds, which antagonize agonist-induced G-protein coupling. These novel CB1 allosteric modulators, possessing photoactivatable functionalities, provide valuable tools for future photo-affinity labeling and mapping the CB1 allosteric binding site(s).


Asunto(s)
Indoles/síntesis química , Indoles/farmacología , Luz , Receptor Cannabinoide CB1/metabolismo , Regulación Alostérica/efectos de los fármacos , Regulación Alostérica/efectos de la radiación , Técnicas de Química Sintética , Células HEK293 , Humanos , Indoles/química , Receptor Cannabinoide CB1/química
2.
Molecules ; 20(12): 22272-85, 2015 Dec 11.
Artículo en Inglés | MEDLINE | ID: mdl-26690407

RESUMEN

Bedaquiline is the first FDA-approved new chemical entity to fight multidrug-resistant tuberculosis in the last forty years. Our group replaced the quinoline ring with a naphthalene ring, leading to a new type of triarylbutanol skeleton. An asymmetric synthetic route was established for our bedaquiline analogues, and the goal of assigning their absolute configurations was achieved by comparison of experimental and calculated electronic circular dichroism spectra, and was confirmed by the combined use of circular dichroism and NMR spectroscopy.


Asunto(s)
Antituberculosos/síntesis química , Diarilquinolinas/química , Naftalenos/química , Quinolinas/química , Dicroismo Circular , Diseño de Fármacos , Espectroscopía de Resonancia Magnética , Modelos Moleculares , Estereoisomerismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA